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Abstract In this paper, we present two remotely adjustable
check-valves with an electrochemical release mechanism
for implantable biomedical microsystems. These valves allow one to vary the opening pressure set-point and flow
resistance over a period of time. The first design consists
of a micromachined check-valve array using a SU-8 polymer structural layer deposited on the top of a gold sacrificial layer. The second design is based on a variable length
cantilever beam structure with a gold sacrificial layer. The
adjustable cantilever-beam structure is fabricated by gold
thermo-compression bond of a thin silicon wafer over a
glass substrate. In both designs, the evaporated gold can
be electrochemically dissolved using a constant DC current via a telemetry link. In the first design the dissolution simply opens up individual outlets, while in the second design, gold anchors are sequentially dissolved hence
increasing the effective length of the cantilever beam (reducing the opening pressure). A current density of 35 mA/cm2
is used to dissolve the gold sacrificial layers. Both gravity and syringe-pump driven flow are used to characterize the valve performance. A multi-stage fluidic performance (e.g. flow resistance and opening pressure) is clearly
demonstrated.
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1 Introduction
Micromachined passive check-valves play an important
role in a variety of implantable biomedical microsystems
(e.g., drug delivery and therapeutic pressure relief devices)
(Gretzinger et al., 1995; Wang et al., 1999; Low et al., 2000;
Qing et al., 2001). In many applications, it is highly desirable
to be able to vary the opening pressure set-point and flow resistance over a period of time (Pan et al., 2002, 2005). For
example, valved glaucoma drainage devices (valved-GDDs)
incorporate a passive check valve to reduce the intra-ocular
pressure (IOP). Recent studies have shown that subsequent to
the fibrous capsule formation around valved-GDDs after implantation, the IOP elevates significantly due to the additive
resistance from the nanoporous structure of the fibrous capsule (Pan et al., 2003, 2005). Currently, there is no good solution to this problem other than performing another GDD implantation surgery, which leads to other complications such
as bifocal problem (Shields, 1998). Therefore, the ability to
remotely change the set-point after implantation provides the
surgeon with the flexibility to regulate the IOP in the postoperation period. Other diseases, such as hydrocephalus,
which require implantable pressure relief devices, could also
benefit from this post-implant adjustment capability (Yoon
et al., 2004). This paper reports on the fabrication and test
of two designs of wireless, electrochemically-released, micromachined check-valves for implantable biomedical microsystems. Figure 1 shows a schematic of a wireless MEMS
check-valve implanted on an eye, which could be remotely
adjusted through an inductively powered telemetry link. Gold
sacrificial layers or anchors are used to activate micromaSpringer
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chined check-valves. This activation mechanism is based
on the electrochemical dissolution of a thin gold membrane
which occurs through the formation of water-soluble chlorogold (III) complexes in the saline solution (Santini et al.,
1999, 2000). The design, fabrication and test of two microvalves will be described in the following sections.

8 layer is used as the microvalve structural material. SU-8
polymer is a negative photoresist, which is commonly used in
high-aspect-ratio micromachining. Recent studies have indicated its suitability as a structural material with exceptional
mechanical properties and good chemical stability. In addition, in vivo studies by Kotzar, et al. have shown that SU-8
is also biocompatible making it useful for implantable applications. Table 1 summarizes important thermomechanical
properties of SU-8 (LaBianca and Delorme, 1995; Guerin
et al., 1997; Lorenz et al., 1997, 1998).
The SU-8 layer is deposited on the top of a gold sacrificial layer which can be electrochemically etched through
the application of a constant DC voltage (0.8–1.2 volts with
respect to a saturated calomel reference electrode) or current
(Santini et al., 1999, 2000). Gold dissolution occurs through
the formation of water-soluble chloro-gold (III) complexes
(Santini et al., 1999, 2000). This voltage/current can be
easily generated via a telemetry link enabling one to remotely address and activate individual microvalves, which
allows discretely decreasing the overall flow resistance of the
device.

2 Design and fabrication of the SU-8 flap microvalve

2.2 Fabrication

2.1 Design

The microvalve array is fabricated using standard microelectromechanical system (MEMS) processes including chemical vapor deposition, lift-off, reactive ion etching and SU-8
photolithography. Figure 3 shows the fabrication process. It
starts with silicon wafers with a 2 µm low-pressure chemical
vapor deposition (LPCVD) low-stress silicon nitride coating

Fig. 1 Schematic of a wireless MEMS check-valve for an implantable
glaucoma drainage device

Figure 2 shows a 3D schematic representation of the device
and its working principle. The device is composed by an array of micromachined check-valves working in parallel and
connected to a silastic medical tubing. As can be seen, a SUFig. 2 A 3D schematic of an
array of micromachined
check-valves connected to a
silastic medical tubing with its
working principle
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Fig. 3 Fabrication process for the SU8 check valve: (1) LPCVD of
low stress silicon nitride; (2) e-beam evaporation and lift-off patterning
of Ti/Au layer; (3) RIE and DRIE of silicon substrate from backside; (4)
photolithography of SU-8 layer; (5) RIE of top nitride from backside;
(6) electrochemical dissolution of gold membrane
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on both sides. A chromium/gold (100 Å/3000 Å) layer is then
deposited (e-beam evaporation) and patterned (lift-off). This
layer acts both as the electrochemically actuated layer and
as the electrical connection and bonding pads. The counter
electrodes are patterned on this layer as well. Backside nitride and silicon are etched by reactive ion etching (RIE)
and deep reactive ion etching (DRIE), respectively. Squareshaped orifices under each flap microvalve and packaging
trenches (which will be discussed in detail in following
section) are formed during these etch steps. SU-8 5 (MicroChem Corp., MA) is spun on top of the gold layer to
serve as the structural and protective layer. The wafers are
cleaned in isopropyl alcohol (IPA) prior to application of
the SU-8 film. To achieve a better uniformity, the wafers
are first accelerated to 3000 rpm over 5 sec followed by
30 sec of spinning at 3000 rpm. Subsequently, a two-stage
soft bake is performed (1 min at 65◦ C and 5 min at 95◦ C).
The wafers are then exposed to the UV source for 20 sec.
A two-step post-exposure bake (PEB) is performed at 65◦ C
and 95◦ C for 1 and 5 min, respectively. Optimum crosslink density is obtained through careful adjustments of the
exposure and PEB process condition. SU-8 is then developed for 2 min followed by a rinse in IPA. An extra hard
bake step at 150◦ C for 5 to 10 min is required for a structural SU-8 layer. Due to its large internal stress, numerous
small cracks are usually formed in the SU-8 layer. The final
hard bake eliminates the cracks and improves the mechanical
robustness and chemical resistance. 3 × 3 and 4 × 4 arrays
(total dimensions 2 × 2 and 4 × 4 mm2 ) each containing two
different size valves (50 × 50 and 100 × 100 µm2 flow channels) are fabricated and tested. Figure 4 shows a photograph
of the 3 × 3 microvalve array bonded to a silastic medical tubing, along with a close-up micrograph of individual
valves.

Fig. 4 A photograph of the 3 × 3 microvalve array bonded to a silastic medical tubing, along with a close-up micrograph of individual valves
Springer
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Fig. 5 A perspective view of
the microvalve along with its
fluidic schematic

3 Design and fabrication of microvalve with a variable
length cantilever-beam structure
3.1 Design
Using the same electrochemical dissolution mechanism as
the SU-8 flap microvalve array, an alternative approach using a variable length cantilever-beam structure is also developed. Figure 5 shows a perspective view of the microvalve
along with its fluidic schematic. It consists of a silicon cantilever beam bonded to a glass bottom plate containing an
ultrasonically drilled inlet hole. The bonding is done using gold thermo-compression technique over selected areas
defined by an array of gold anchor pads on the silicon substrate and thin gold strips on the glass substrate. An array
of 10 × 10 µm2 gold anchor pads with 10 µm separation is
used in our design. On the glass substrate, the gold pattern
is a continuous narrow strip of 50 µm wide connected to
the outside pads. The gold anchors and strips define various
lengths and hence opening pressures for the valve. The strips
can be electrochemically removed in sequence, lowering the
opening pressure accordingly.
3.2 Fabrication
Figure 6 shows the fabrication sequence. The silicon substrate fabrication process starts with a thermal oxidation step
of a thin silicon substrate (200 µm thick). A 0.5 µm silicon
dioxide is grown to prevent silicon diffusion during thermocompression bond (Tsau et al., 2002 #44); this also serves as
an isolation layer during the electrochemical dissolution. The
backside oxide layer is patterned for the final etching step.
A Ti/Au (10 nm/1.0 µm) bonding layer is then deposited by
electron beam evaporation and patterned on the silicon wafer
Springer

Fig. 6 Fabrication process includes: (1) thermal oxidation of silicon
wafer; (2) e-beam evaporation and patterning of Ti/Au; (3) ultrasonic
drilling of the flow channel; (4) thermo-compression bonding of SiGlass; (5) DRIE Si from the backside followed by wafer dicing
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mains before wafer alignment. During the alignment process
of two substrates, three spacers and three clamps on a bonder
fixture are loaded consequentially to separate the wafers and
hold them in position. The gold-to-gold thermo-compression
is carried out in Karl Suss SB6 VAC bonder (Suss MicroTec,
Germany) under atmospheric pressure. Following the withdrawal of the clamps, the temperature is ramped up and
stabilized at 350◦ C for 30 min, 0.01 MPa pressure is applied
over the wafer and spacers are withdrawn. Then a bonding
pressure of 0.1 MPa is applied across the two substrates for
15 min (corresponding to 5 MPa of pressure on the gold
anchor pads). Afterwards, the temperature is ramped down
slowly (Tsau et al., 2002). To machine the silicon substrate
into a cantilever shape, we use deep reactive ion etch (DRIE)
from the backside of the silicon wafer. Finally, the devices
are diced and separated into individual 8 × 8 mm2 chips. The
overall size is compatible with the currently implanted glaucoma drainage devices, e.g., Ahmed glaucoma valve (which
is the most widely used implantable devices) is 13 mm wide,
16 mm long, and 2 mm thick. Figure 7 shows photographs of
the front and the backside of the adjustable micromachined
check-valve.

4 Results and discussion

Fig. 7 Photographs of (a) the front view and (b) the backside view of
the adjustable micromachined check-valve

by lift-off process to create an array of gold bonding pads.
The glass fabrication process starts with the deposition and
patterning of the Ti/Au (10 nm/1.0 µm) bonding strips on
a Pyrex 7740 glass substrate. A flow channel of 600 µm in
diameter is then ultrasonically drilled on the glass substrate.
The bonding surfaces of the two substrates are exposed to
oxygen plasma for 5 min to completely remove organic re-

The electrochemical activition of individual valves is carried out using a constant current source and an external
gold counter electrode, as shown in Fig. 8. Constant-voltage
schemes require a stable reference electrode in addition to
the counter electrode, which makes this option less appealing
for integrated and remotely operated systems. Both gravity
and syringe-pump driven flow were used to characterize the
valve performance (Porter et al., 1997). These can be easily achieved by using the setup shown in Fig. 9. The setup
consists of a syringe pump (KDS Inc.) connected to a glass
standpipe (1.1 mm ID) or a pressure sensor via a 3-way stopcock. The third outlet is connected to the valve through a

Fig. 8 A schematic of the
telemetry release setup

Springer
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gravitational force of the fluid head, which forces the valve
open and drains the fluid out until the gravitational head is
reduced to the level at which the valve is closed. The flow
rate through the device can be calculated as
Q=A

dh
dt

(1)

where A is the cross-section area of the standpipe and h is
the height of the fluid. The flow resistance, defined by the
pressure drop P over the flow rate Q, can be obtained from
Fig. 9 Schematic of the in vitro microfluidic test setup for the microvalves

R=

P
P
= dh
Q
A dt

(2)

This configuration allows the flow resistance to be measured
over a wide range of flow rates. In the syringe-pump driven
tests, i.e., constant flow tests, the syringe pump provides a
constant flow rate and pressure variation across the valve is
monitored using the standpipe or a pressure sensor. This configuration also simulates the operation of pressure activated
passive check valves encountered in actual physiological settings (e.g., constant aqueous humor inflow in the eye) (Brown
and Brubaker, 1989).
4.1 SU-8 flap microvalve

Fig. 10 Current density vs. release time for gold membranes
(0.02 mm2 of exposed area)

silastic tubing. All tests are carried out at the atmospheric
pressure and room temperature.
In the gravity-driven flow tests, the branch connected to
the syringe pump is closed and the valve is subjected to the

Fig. 11 Photographs of the
valve (left) before and (right)
after release
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Initially, we carried out a series of tests in order to determine
the required current density for the electrochemical release.
Figure 10 shows the results of these tests in terms of current
density (5–350 mA/cm2 ) vs. the release time for 3000 Å gold
membranes having 0.02 mm2 of exposed area. At a current
density of 35 mA/cm2 , the exposed areas are completely
removed in 30 sec with the final release completed in 1–2 min
(i.e., 5–10 µm undercut which is critical for the valve release
process). Bubble generation due to electrolysis was observed
at current densities larger than 35 mA/cm2 . These bubbles
prevent the undercut process by masking the unexposed gold
areas. Figure 11 shows photographs of a micromachined

Biomed Microdevices (2007) 9:385–394
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Fig. 12 The measurement
results of the pressure head (left)
and flow resistance (right) vs.
flow rate of microvalves of (a)
50 × 50 µm2 flow channel and
(b) 100 × 100 µm2 flow channel

check-valve before and after the electrochemical release by
applying a current density of 35 mA/cm2 for 1 min. We also
preformed bending test to study the flexibility and reliability
of the SU-8 flaps. For a 5 µm-thick 100 µm-long SU-8 flap,
45 degree bending test is conducted by applying a force
through a probe. After 100 cycles of bending, no apparent
deformation is observed.
Figure 12 shows the flow measurement results (pressure
and flow resistance vs. flow rate) of two individual check-

valves, one flow channel is 50 × 50 µm2 and the other is
100 × 100 µm2 from the gravity characterization test. It indicates a nonlinear flow behavior of a decreasing flow resistance with closing pressures of 8.8 and 1.4 mmHg. As
expected, the valve exhibits nonlinear fluidic behavior due
to the pressure response of the cantilever beam structure,
i.e., the higher the pressure, the larger the displacement of
valve flap, and therefore the much larger the flow rate and
smaller the flow resistance. Figure 13 shows the pressure

Springer
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Fig. 13 The pressure
measurement results for the
check-valve characteristic tests
illustrating the basic forward
operation of the device

measurement results for syringe-pump driven constant flow
tests of 4 microvalves released consequently, which are all
50 × 50 µm2 flow channel design, at a physiologically related flow rate of 10 µL/min. The multi-stage fluidic performance has been demonstrated clearly.
4.2 Variable length cantilever microvalve
For these microvalves, similar to the previous results, a
current density of 35 mA/cm2 resulted in the release of

gold anchors in 2 min and gold strips in 10 min. Figure 14
shows microscopic photographs of the valve gold strip
before and after release. Figure 15 shows the measurement
results of the pressure head (left) and flow resistance (right)
vs. flow rate of a microvalve with the cantilever flap having
a width of 1.5 mm and a length of 4 mm. As expected, the
valve exhibits nonlinear fluidic behavior due to the pressure
response of the cantilever beam structure, i.e., the higher
the pressure, the larger the displacement of valve flap, and
therefore the much larger the flow rate and smaller the
flow resistance. Figure 15 also indicates a closing pressure
of 7.2 mmHg. Following the dissolution of each anchor,
deionized (DI) water at 10 µL/min flow rate is injected into
the microvalve. Figure 16 shows the pressure measurement
results for the check-valve illustrating the basic forward
operation of the device. Opening pressures of 178, 78, 26,
12 mmHg and stablized pressure of 145, 72, 22, 7 mmHg
show four-stage performance by releasing the gold strips
sequentially.

5 Conclusions

Fig. 14 Microscopic photographs of a gold strip in the variable length
cantilever valve (a) before and (b) after electrochemical release
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In this paper, we report on two designs of remotely adjustable
check-valves for implantable biomedical microsystems,
based on an electrochemical release mechanism. Release
tests with a telemetrically powered current source indicated
an optimum current density of 35 mA/cm2 . Both gravity and
syringe-pump driven flow are used to characterize the valve
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Fig. 15 The measurement
results of the pressure head (left)
and flow resistance (right) vs.
flow rate of a microvalve with
the cantilever flap having a
width of 1.5 mm and a length of
4 mm

Fig. 16 The pressure
measurement results for the
check-valve characteristic tests
illustrating the basic forward
operation of the device

performance. The multi-stage fluidic performance (e.g. flow
resistance and opening pressure) has been demonstrated
clearly.
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